Cell Line Development Market Size, Share & Trends Report

Cell Line Development Market Size, Share & Trends Analysis Report by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By Application, By Technology, And Segment Forecasts, 2012 - 2022

  • Published Date: Feb, 2018
  • Base Year for Estimate: 2014
  • Report ID: 978-1-68038-481-9
  • Format: Electronic (PDF)
  • Historical Data: 2012 - 2014
  • Number of Pages: 154

Table of Content

Chapter 1. Methodology and Scope
                   1.1. Research methodology
                   1.2. Research scope &assumption
                   1.3. List of data sources
Chapter 2. Executive Summary
                   2.1. Cell Line Development - Industry Snapshot and Key Buying Criteria, 2012 - 2022
Chapter 3. Cell Line Development Industry Outlook
                   3.1. Cell line development market segmentation
                   3.2. Cell line development market size and growth prospects, 2012 - 2022
                   3.3. Cell line development market dynamics
                        3.3.1. Market driver analysis
                        3.3.2. Market restraint analysis
                   3.4. Key opportunities prioritized
                   3.5. Industry Analysis - Porter's
                   3.6. Cell line development competitive landscape, 2014
                        3.6.1. Company market share analysis, 2014
                        3.6.2. Market position analysis, 2014 (based on products, regional presence, and strategic initiatives)
                   3.7. Cell line development market PESTEL analysis, 2014
Chapter 4. Cell Line Development Product Outlook
                   4.1. Cell line development market share by product, 2014 & 2022
                   4.2. Reagents and media
                        4.2.1. Reagents and media market estimates and forecasts, 2012 - 2022 (USD million)
                   4.3. Equipment
                        4.3.1. Equipment market estimates and forecasts, 2012 - 2022 (USD million)
                        4.3.2. Incubators
                             4.3.2.1. Incubators market estimates and forecasts, 2012 - 2022 (USD million)
                        4.3.3. Centrifuges
                             4.3.3.1. Centrifuges market estimates and forecasts, 2012 - 2022 (USD million)
                        4.3.4. Bioreactors
                             4.3.4.1. Bioreactors market estimates and forecasts, 2012 - 2022 (USD million)
                        4.3.5. Storage equipment
                             4.3.5.1. Storage equipment market estimates and forecasts, 2012 - 2022 (USD million)
                        4.3.6. Microscopes
                             4.3.6.1. Microscopes market estimates and forecasts, 2012 - 2022 (USD million)
                   4.4. Accessories and consumables
                        4.4.1. Accessories and consumables market estimates and forecasts, 2012 - 2022 (USD million)
Chapter 5. Cell Line Development Source Outlook
                   5.1. Cell line development market share by source, 2014 & 2022
                   5.2. Mammalian
                        5.2.1. Mammalian market estimates and forecasts, 2012 - 2022 (USD million)
                   5.3. Non-mammalian
                        5.3.1. Non-mammalian market estimates and forecasts, 2012 - 2022 (USD million)
                        5.3.2. Insects
                             5.3.2.1. Insects market estimates and forecasts, 2012 - 2022 (USD million)
                        5.3.3. Amphibians
                             5.3.3.1. Amphibians market estimates and forecasts, 2012 - 2022 (USD million)
Chapter 6. Cell Line Development Type of Cell Lines Outlook
                   6.1. Cell line development market share, by type of cell lines, 2014 & 2022
                   6.2. Recombinant cell lines
                        6.2.1. Recombinant cell lines market estimates and forecasts, 2012 - 2022 (USD million)
                   6.3. Hybridomas
                        6.3.1. Hybridomas market estimates and forecasts, 2012 - 2022 (USD million)
                   6.4. Continuous cell lines
                        6.4.1. Continuous cell lines market estimates and forecasts, 2012 - 2022 (USD million)
                   6.5. Primary cell lines
                        6.5.1. Primary cell lines market estimates and forecasts, 2012 - 2022 (USD million)
Chapter 7. Cell Line Development Application Outlook
                   7.1. Cell line development market share, by application, 2014 & 2022
                   7.2. Bioproduction
                        7.2.1. Bioproduction market estimates and forecasts, 2012 - 2022 (USD million)
                   7.3. Drug discovery
                        7.3.1. Drug discovery market estimates and forecasts, 2012 - 2022 (USD million)
                   7.4. Toxicity testing
                        7.4.1. Toxicity testing market estimates and forecasts, 2012 - 2022 (USD million)
                   7.5. Vaccines
                        7.5.1. Vaccines market estimates and forecasts, 2012 - 2022 (USD million)
                   7.6. Tissue engineering
                        7.6.1. Tissue engineering market estimates and forecasts, 2012 - 2022 (USD million)
                   7.7. Others
                        7.7.1. Others market estimates and forecasts, 2012 - 2022 (USD million)
Chapter 8. Cell Line Development Regional Outlook
                   8.1. Cell line development market share, by region, 2014 & 2022
                   8.2. North America
                        8.2.1. North America cell line development market estimates and forecasts, by product, 2012 - 2022 (USD million)
                             8.2.1.1. U.S.
                                 8.2.1.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.2.1.2. Canada
                                 8.2.1.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.2.2. North America cell line development market estimates and forecasts, by source, 2012 - 2022 (USD million)
                             8.2.2.1. U.S.
                                 8.2.2.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.2.2.2. Canada
                                 8.2.2.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.2.3. North America cell line development market estimates and forecasts, by type of cell lines, 2012 - 2022 (USD million)
                             8.2.3.1. U.S.
                                 8.2.3.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.2.3.2. Canada
                                 8.2.3.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.2.4. North America cell line development market estimates and forecasts, by application, 2012 - 2022 (USD million)
                             8.2.4.1. U.S.
                                 8.2.4.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.2.4.2. Canada
                                 8.2.4.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                   8.3. Europe
                        8.3.1. Europe cell line development market estimates and forecasts, by product, 2012 - 2022 (USD million)
                             8.3.1.1. U.K.
                                 8.3.1.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.3.1.2. Germany
                                 8.3.1.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.3.2. Europe cell line development market estimates and forecasts, by source, 2012 - 2022 (USD million)
                             8.3.2.1. U.K.
                                 8.3.2.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.3.2.2. Germany
                                 8.3.2.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.3.3. Europe cell line development market estimates and forecasts, by type of cell lines, 2012 - 2022 (USD million)
                             8.3.3.1. U.K.
                                 8.3.3.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.3.3.2. Germany
                                 8.3.3.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.3.4. Europe cell line development market estimates and forecasts, by application, 2012 - 2022 (USD million)
                             8.3.4.1. U.K.
                                 8.3.4.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.3.4.2. Germany
                                 8.3.4.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                   8.4. Asia Pacific
                        8.4.1. Asia Pacific cell line development market estimates and forecasts, by product, 2012 - 2022 (USD million)
                             8.4.1.1. Japan
                                 8.4.1.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.1.2. China
                                 8.4.1.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.1.3. India
                                 8.4.1.3.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.4.2. Asia Pacific cell line development market estimates and forecasts, by source, 2012 - 2022 (USD million)
                             8.4.2.1. Japan
                                 8.4.2.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.2.2. China
                                 8.4.2.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.2.3. India
                                 8.4.2.3.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.4.3. Asia Pacific cell line development market estimates and forecasts, by type of cell lines, 2012 - 2022 (USD million)
                             8.4.3.1. Japan
                                 8.4.3.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.3.2. China
                                 8.4.3.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.3.3. India
                                 8.4.3.3.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.4.4. Asia Pacific cell line development market estimates and forecasts, by application, 2012 - 2022 (USD million)
                             8.4.4.1. Japan
                                 8.4.4.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.4.2. China
                                 8.4.4.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.4.4.3. India
                                 8.4.4.3.1. Cell line development market estimates and forecasts, 2012 - 2022
                   8.5. Latin America
                        8.5.1. Latin America cell line development market estimates and forecasts, by product, 2012 - 2022 (USD million)
                             8.5.1.1. Mexico
                                 8.5.1.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.5.1.2. Brazil
                                 8.5.1.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.5.2. Latin America cell line development market estimates and forecasts, by source, 2012 - 2022 (USD million)
                             8.5.2.1. Mexico
                                 8.5.2.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.5.2.2. Brazil
                                 8.5.2.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.5.3. Latin America cell line development market estimates and forecasts, by type of cell lines, 2012 - 2022 (USD million)
                             8.5.3.1. Mexico
                                 8.5.3.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.5.3.2. Brazil
                                 8.5.3.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.5.4. Latin America cell line development market estimates and forecasts, by application, 2012 - 2022 (USD million)
                             8.5.4.1. Mexico
                                 8.5.4.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                             8.5.4.2. Brazil
                                 8.5.4.2.1. Cell line development market estimates and forecasts, 2012 - 2022
                   8.6. MEA
                        8.6.1. MEA cell line development market estimates and forecasts, by product, 2012 - 2022 (USD million)
                             8.6.1.1. South Africa
                                 8.6.1.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.6.2. MEA cell line development market estimates and forecasts, by source, 2012 - 2022 (USD million)
                             8.6.2.1. South Africa
                                 8.6.2.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.6.3. MEA cell line development market estimates and forecasts, by type of cell lines, 2012 - 2022 (USD million)
                             8.6.3.1. South Africa
                                 8.6.3.1.1. Cell line development market estimates and forecasts, 2012 - 2022
                        8.6.4. MEA cell line development market estimates and forecasts, by application, 2012 - 2022 (USD million)
                             8.6.4.1. South Africa
                                 8.6.4.1.1. Cell line development market estimates and forecasts, 2012 - 2022
Chapter 9. Competitive Landscape
                   9.1. General Electric Company (GE Healthcare)
                        9.1.1. Company Overview
                        9.1.2. Financial Performance
                        9.1.3. Product Benchmarking
                        9.1.4. Strategic Initiatives
                   9.2. Thermo Fisher Scientific Inc.
                        9.2.1. Company Overview
                        9.2.2. Financial Performance
                        9.2.3. Product Benchmarking
                        9.2.4. Strategic Initiatives
                   9.3. Public Health England (European Collection of Cell Cultures)
                        9.3.1. Company Overview
                        9.3.2. Financial Performance
                        9.3.3. Product Benchmarking
                        9.3.4. Strategic Initiatives
                   9.4. Lonza
                        9.4.1. Company Overview
                        9.4.2. Financial Performance
                        9.4.3. Product Benchmarking
                        9.4.4. Strategic Initiatives
                   9.5. Sigma-Aldrich Co.
                        9.5.1. Company Overview
                        9.5.2. Financial Performance
                        9.5.3. Product Benchmarking
                        9.5.4. Strategic Initiatives
                   9.6. WuXi AppTec
                        9.6.1. Company Overview
                        9.6.2. Financial Performance
                        9.6.3. Product Benchmarking
                        9.6.4. Strategic Initiatives
                   9.7. ATCC (American Type Culture Collection)
                        9.7.1. Company Overview
                        9.7.2. Financial Performance
                        9.7.3. Product Benchmarking
                        9.7.4. Strategic Initiatives
                   9.8. Sartorius AG
                        9.8.1. Company Overview
                        9.8.2. Financial Performance
                        9.8.3. Product Benchmarking
                        9.8.4. Strategic Initiatives
                   9.9. Corning Incorporated
                        9.9.1. Company Overview
                        9.9.2. Financial Performance
                        9.9.3. Product Benchmarking
                        9.9.4. Strategic Initiatives
                   9.10. Selexis
                        9.10.1. Company Overview
                        9.10.2. Financial Performance
                        9.10.3. Product Benchmarking
                        9.10.4. Strategic Initiatives
                   9.11. Vista Biologicals Corporation
                        9.11.1. Company Overview
                        9.11.2. Financial Performance
                        9.11.3. Product Benchmarking
                        9.11.4. Strategic Initiatives
                   9.12. Eubiologics CO., LTD.
                        9.12.1. Company Overview
                        9.12.2. Financial Performance
                        9.12.3. Product Benchmarking
                        9.12.4. Strategic Initiatives
                   9.13. Paragon Bioservices, Inc.
                        9.13.1. Company Overview
                        9.13.2. Financial Performance
                        9.13.3. Product Benchmarking
                        9.13.4. Strategic Initiatives
                   9.14. Cobra Biologics
                        9.14.1. Company Overview
                        9.14.2. Financial Performance
                        9.14.3. Product Benchmarking
                        9.14.4. Strategic Initiatives
                   9.15. Gallus Biopharmaceuticals (Acquired by Patheon)
                        9.15.1. Company Overview
                        9.15.2. Financial Performance
                        9.15.3. Product Benchmarking
                        9.15.4. Strategic Initiatives
                   9.16. Samsung Biologics
                        9.16.1. Company Overview
                        9.16.2. Financial Performance
                        9.16.3. Product Benchmarking
                        9.16.4. Strategic Initiatives
                   9.17. Naeja
                        9.17.1. Company Overview
                        9.17.2. Financial Performance
                        9.17.3. Product Benchmarking
                        9.17.4. Strategic Initiatives
                   9.18. Aragen Bioscience
                        9.18.1. Company Overview
                        9.18.2. Financial Performance
                        9.18.3. Product Benchmarking
                        9.18.4. Strategic Initiatives
                   9.19. GVK BIO
                        9.19.1. Company Overview
                        9.19.2. Financial Performance
                        9.19.3. Product Benchmarking
                        9.19.4. Strategic Initiatives
                   9.20. PCT
                        9.20.1. Company Overview
                        9.20.2. Financial Performance
                        9.20.3. Product Benchmarking
                        9.20.4. Strategic Initiatives
                   9.21. Apath
                        9.21.1. Company Overview
                        9.21.2. Financial Performance
                        9.21.3. Product Benchmarking
                        9.21.4. Strategic Initiatives
                   9.22. Cell for cure
                        9.22.1. Company Overview
                        9.22.2. Financial Performance
                        9.22.3. Product Benchmarking
                        9.22.4. Strategic Initiatives
                   9.23. TRL
                        9.23.1. Company Overview
                        9.23.2. Financial Performance
                        9.23.3. Product Benchmarking
                        9.23.4. Strategic Initiatives
                   9.24. Episteme
                        9.24.1. Company Overview
                        9.24.2. Financial Performance
                        9.24.3. Product Benchmarking
                        9.24.4. Strategic Initiatives
                   9.25. Catalent
                        9.25.1. Company Overview
                        9.25.2. Financial Performance
                        9.25.3. Product Benchmarking
                        9.25.4. Strategic Initiatives
                   9.26. Bioceros
                        9.26.1. Company Overview
                        9.26.2. Financial Performance
                        9.26.3. Product Benchmarking
                        9.26.4. Strategic Initiatives
                   9.27. Antitope
                        9.27.1. Company Overview
                        9.27.2. Financial Performance
                        9.27.3. Product Benchmarking
                        9.27.4. Strategic Initiatives
                   9.28. Promocell
                        9.28.1. Company Overview
                        9.28.2. Financial Performance
                        9.28.3. Product Benchmarking
                        9.28.4. Strategic Initiatives
                   9.29. Cyagen
                        9.29.1. Company Overview
                        9.29.2. Financial Performance
                        9.29.3. Product Benchmarking
                        9.29.4. Strategic Initiatives


List of Tables

TABLE 1 Cell Line Development - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 3 Global cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 4 Global cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 5 Global cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 6 Global cell line development market, by region, 2012 - 2022 (USD Million)
TABLE 7 Cell line development - Key market driver analysis
TABLE 8 Global cancer incidences, 2012
TABLE 9 North America cancer incidences in 2012
TABLE 10 Europe cancer incidences, 2012
TABLE 11 Asia cancer incidences, 2012
TABLE 12 Africa cancer incidences, 2012
TABLE 13 Australia and New Zealand cancer incidences in 2012
TABLE 14 Cell line development - Key market restraint analysis
TABLE 15 North America cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 16 North America cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 17 North America cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 18 North America cell line development market, by nonmammalian source, 2012 - 2022 (USD Million)
TABLE 19 North America cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 20 North America cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 21 U.S. cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 22 U.S cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 23 U.S. cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 24 U.S. cell line development market, by nonmammalian source, 2012 - 2022 (USD Million)
TABLE 25 U.S. cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 26 U.S. Cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 27 Canada cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 28 Canada cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 29 Canada cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 30 Canada cell line development market, by non-mammalian source, 2012 - 2022 (USD Million)
TABLE 31 Canada cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 32 Canada cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 33 Europe cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 34 Europe cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 35 Europe cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 36 Europe cell line development market, by non-mammalian source, 2012 - 2022 (USD Million)
TABLE 37 Europe cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 38 Europe cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 39 U.K. cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 40 U.K. cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 41 U.K. cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 42 U.K. cell line development market, by non-mammalian source, 2012 - 2022 (USD Million)
TABLE 43 U.K. cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 44 U.K. cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 45 Germany cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 46 Germany cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 47 Germany cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 48 Germany cell line development market, by non-mammalian source, 2012 - 2022 (USD Million)
TABLE 49 Germany cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 50 Germany cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 51 Asia Pacific cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 52 Asia Pacific cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 53 Asia Pacific cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 54 Asia Pacific cell line development market, by non-mammalian source, 2012 - 2022 (USD Million)
TABLE 55 Asia Pacific cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 56 Asia Pacific cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 57 Japan cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 58 Japan cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 59 Japan cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 60 Japan cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 61 Japan cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 62 Japan cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 63 China cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 64 China cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 65 China cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 66 China cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 67 China cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 68 China cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 69 India cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 70 India cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 71 India cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 72 India cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 73 India cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 74 India cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 75 Latin America cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 76 Latin America cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 77 Latin America cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 78 Latin America cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 79 Latin America cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 80 Latin America cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 81 Brazil cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 82 Brazil cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 83 Brazil cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 84 Brazil cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 85 Brazil cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 86 Brazil cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 87 Mexico cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 88 Mexico cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 89 Mexico cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 90 Mexico cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 91 Mexico cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 92 Mexico cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 93 MEA cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 94 MEA cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 95 MEA cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 96 MEA cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 97 MEA cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 98 MEA cell line development market, by application, 2012 - 2022 (USD Million)
TABLE 99 South Africa cell line development market, by product, 2012 - 2022 (USD Million)
TABLE 100 South Africa cell line development market, by equipment, 2012 - 2022 (USD Million)
TABLE 101 South Africa cell line development market, by source, 2012 - 2022 (USD Million)
TABLE 102 South Africa cell line development market, by non mammalian source, 2012 - 2022 (USD Million)
TABLE 103 South Africa cell line development market, by type of cell lines, 2012 - 2022 (USD Million)
TABLE 104 South Africa cell line development market, by application, 2012 - 2022 (USD Million)


List of Figures

FIG. 1 Cell line development: Market segmentation
FIG. 2 Global cell line development market, 2012 - 2022 (USD Million)
FIG. 3 Cell line development: Market dynamics
FIG. 4 Key opportunities prioritized
FIG. 5 Cell line development market - Porter’s analysis
FIG. 6 Cell line development company market share, 2014
FIG. 7 Other market players, 2014
FIG. 8 Cell line development market positioning, 2014
FIG. 9 Cell line development market - PESTEL analysis
FIG. 10 Cell line development revenue share by product, 2014 & 2022
FIG. 11 Reagents and media market, 2012 - 2022 (USD Million)
FIG. 12 Equipment market, 2012 - 2022 (USD Million)
FIG. 13 Incubators market, 2012 - 2022 (USD Million)
FIG. 14 Centrifuges market, 2012 - 2022 (USD Million)
FIG. 15 Bioreactors market, 2012 - 2022 (USD Million)
FIG. 16 Storage equipment market, 2012 - 2022 (USD Million)
FIG. 17 Microscopes market, 2012 - 2022 (USD Million)
FIG. 18 Accessories and consumables market, 2012 - 2022 (USD Million)
FIG. 19 Cell line development revenue share by source, 2014 & 2022
FIG. 20 Mammalian cell line development market, 2012 - 2022 (USD Million)
FIG. 21 Non-mammalian cell line development market, 2012 - 2022 (USD Million)
FIG. 22 Insects cell line development market, 2012 - 2022 (USD Million)
FIG. 23 Amphibians cell line development market, 2012 - 2022 (USD Million)
FIG. 24 Cell line development revenue share by type of cell lines, 2014 & 2022
FIG. 25 Recombinant cell line market, 2012 - 2022 (USD Million)
FIG. 26 Hybridomas market, 2012 - 2022 (USD Million)
FIG. 27 Continuous cell lines market, 2012 - 2022 (USD Million)
FIG. 28 Primary cell lines market, 2012 - 2022 (USD Million)
FIG. 29 Cell line development revenue share by application, 2014 & 2022
FIG. 30 Bioproduction market, 2012 - 2022 (USD Million)
FIG. 31 Drug discovery market, 2012 - 2022 (USD Million)
FIG. 32 Toxicity testing market, 2012 - 2022 (USD Million)
FIG. 33 Tissue engineering market, 2012 - 2022 (USD Million)
FIG. 34 Research market, 2012 - 2022 (USD Million)
FIG. 35 Cell line development market share, by region, 2014 & 2022
FIG. 36 North America cell line development market, 2012 - 2022 (USD Million)
FIG. 37 U.S. cell line development market, 2012 - 2022 (USD Million)
FIG. 38 Canada cell line development market, 2012 - 2022 (USD Million)
FIG. 39 Europe cell line development market, 2012 - 2022 (USD Million)
FIG. 40 U.K. cell line development market, 2012 - 2022 (USD Million)
FIG. 41 Germany cell line development market, 2012 - 2022 (USD million)
FIG. 42 Asia Pacific cell line development market, 2012 - 2022 (USD million)
FIG. 43 Japan cell line development market, 2012 - 2022 (USD million)
FIG. 44 China cell line development market, 2012 - 2022 (USD million)
FIG. 45 India cell line development market, 2012 - 2022 (USD million)
FIG. 46 Latin America cell line development market, 2012 - 2022 (USD million)
FIG. 47 Brazil cell line development market, 2012 - 2022 (USD million)
FIG. 48 Mexico cell line development market, 2012 - 2022 (USD million)
FIG. 49 MEA cell line development market, 2012 - 2022 (USD million)
FIG. 50 South Africa cell line development market, 2012 - 2022 (USD million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.